Table 3.
Percentage Distribution of Different Immunoreactive Forms of S100B and NSE in Different Biofluid Compartments
| Marker |
S100B |
NSE |
||||||
|---|---|---|---|---|---|---|---|---|
| Biofluid |
CSF |
bECF |
CSF |
bECF |
||||
| MW (kDa) | 10 kDa | 60 kDa | 10 kDa | 60 kDa | 50 kDa | 60 kDa | 50 kDa | 60 kDa |
| Patients | ||||||||
| PT 6 | 32.6 | 67.3 | N/A | 100 | 68.6 | 31.3 | 100 | N/A |
| PT 7 | 56.3 | 43.6 | 76.1 | 23.8 | 66.9 | 33.01 | 86.7 | 13.2 |
| PT 10 | 46.3 | 53.6 | N/A | N/A | 38.2 | 61.7 | N/A | N/A |
| PT 11 | 12.6 | 87.32 | 63.8 | 36.1 | 21.3 | 78.6 | 55.9 | 44.08 |
| PT 13 | 23.3 | 76.6 | 100 | N/A | 49.6 | 50.3 | 100 | N/A |
| PT 14 | 17.1 | 82.8 | 89.6 | 10.3 | 13.2 | 86.7 | 78.8 | 21.1 |
| PT 17 | N/A | 100 | 89.4 | 10.5 | 69.6 | 30.3 | 90.3 | 9.6 |
S100B, S100 calcium-binding protein B; NSE, neuron-specific enolase; CSF, cerebrospinal fluid; bECF, brain extracellular fluid; MW, molecular weight; N/A, not applicable.